[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MY141724A - Medicaments containing betamimetic drugs and a novel anticholinesterase drug - Google Patents

Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Info

Publication number
MY141724A
MY141724A MYPI20031338A MYPI20031338A MY141724A MY 141724 A MY141724 A MY 141724A MY PI20031338 A MYPI20031338 A MY PI20031338A MY PI20031338 A MYPI20031338 A MY PI20031338A MY 141724 A MY141724 A MY 141724A
Authority
MY
Malaysia
Prior art keywords
medicaments containing
anticholinesterase drug
betamimetic
drugs
novel
Prior art date
Application number
MYPI20031338A
Inventor
Rolf Dr Banholzer
Ingo Dr Konetzki
Helmut Meissner
Gerd Morschhauser
Michael P Dr Pieper
Gerald Dr Pohl
Richard Dr Reichl
Georg Dr Speck
Christopher John Montague Dr Meade
Michel Dr Pairet
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY141724A publication Critical patent/MY141724A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON BETA2 AGONISTS WITH A LONG-LASTING EFFECT AND SALTS OF A NEW ANTICHOLINERGIC, PROCESSES FOR PREPARING THEM AND THEIR USE IN THE TREATMENT OF RESPIRATORY COMPLAINTS.
MYPI20031338A 2002-04-12 2003-04-10 Medicaments containing betamimetic drugs and a novel anticholinesterase drug MY141724A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (en) 2002-04-12 2002-12-03 Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt

Publications (1)

Publication Number Publication Date
MY141724A true MY141724A (en) 2010-06-15

Family

ID=28458801

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20031338A MY141724A (en) 2002-04-12 2003-04-10 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Country Status (10)

Country Link
EP (1) EP1586574A1 (en)
KR (1) KR20040108719A (en)
AR (1) AR039634A1 (en)
DE (2) DE10256317A1 (en)
EA (1) EA007048B1 (en)
EC (1) ECSP045357A (en)
MY (1) MY141724A (en)
PE (1) PE20040327A1 (en)
TW (1) TWI296928B (en)
ZA (1) ZA200406881B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
DE102004024453A1 (en) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting bronchodilators for the treatment of respiratory diseases
GB0511065D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
GB0511066D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE10050995A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10050994A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
EA200401302A1 (en) 2005-04-28
KR20040108719A (en) 2004-12-24
TW200307550A (en) 2003-12-16
ECSP045357A (en) 2005-01-28
PE20040327A1 (en) 2004-07-12
EP1586574A1 (en) 2005-10-19
TWI296928B (en) 2008-05-21
AR039634A1 (en) 2005-03-02
ZA200406881B (en) 2006-06-28
DE50301052D1 (en) 2005-09-29
EA007048B1 (en) 2006-06-30
DE10256317A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
HRP20040944B1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
IL164373A (en) Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer
IL173371A0 (en) Medicaments for inhalation comprising betamimetics and an anticholinergic
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
EA200801213A1 (en) NEEDLE FOR CALVING CAPSULES WITH INHALATION POWDER
NZ605469A (en) Nalbuphine-based formulations and uses thereof
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
ATE526967T1 (en) INHALATION MEDICATIONS CONTAINING AN ANTICHOLINERGIC AND A BETAMIMETIC
TW200607508A (en) Powder formulations for inhalation, comprising enantiomerically pure beta agonists
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
DE69918961D1 (en) IMPROVED INHALATION PRODUCTS
MXPA05010161A (en) Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases.
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
DE602004019096D1 (en) MEDICAMENTS FOR INHALATION WITH BETAMIMETICS AND ANTICHOLINERGICUM
MXPA04002401A (en) Novel medicaments for inhalation.
MX2009008813A (en) Pharmaceutical composition containing phloroglucinol and paracetamol.
DE50115277D1 (en) DRUG COMPOSITIONS FROM TIOTROPIUM SALTS AND
MY137679A (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
DK1581224T3 (en) Tiotropium-containing drug composition for inhalation
DE602004021815D1 (en) MEDICAMENTS FOR INHALATION WITH STEROIDS AND A NEW FLUORESCARBOXIC ACID ESTER